These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36429562)

  • 1. Cognitive Digital Intervention for Older Patients with Parkinson's Disease during COVID-19: A Mixed-Method Pilot Study.
    Santini S; Rampioni M; Stara V; Di Rosa M; Paciaroni L; Paolini S; Fioretti S; Valenza S; Riccardi GR; Pelliccioni G
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial.
    Hindle JV; Watermeyer TJ; Roberts J; Martyr A; Lloyd-Williams H; Brand A; Gutting P; Hoare Z; Edwards RT; Clare L
    Trials; 2016 Mar; 17():152. PubMed ID: 27000036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT.
    Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC
    Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease.
    van Balkom TD; Berendse HW; van der Werf YD; Twisk JWR; Zijlstra I; Hagen RH; Berk T; Vriend C; van den Heuvel OA
    BMC Neurol; 2019 Jul; 19(1):179. PubMed ID: 31366395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition, coping, and outcome in Parkinson's disease.
    Hurt CS; Landau S; Burn DJ; Hindle JV; Samuel M; Wilson K; Brown RG;
    Int Psychogeriatr; 2012 Oct; 24(10):1656-63. PubMed ID: 22612910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of repetitive transcranial magnetic stimulation on cognitive impairment in Parkinson's disease with dementia: Pilot study.
    Khedr EM; Mohamed KO; Ali AM; Hasan AM
    Restor Neurol Neurosci; 2020; 38(1):55-66. PubMed ID: 31815705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson's: Is the future digital?
    Das J; Barry G; Walker R; Vitorio R; Morris R; Stuart S
    PLoS One; 2023; 18(6):e0285100. PubMed ID: 37319251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
    Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goal management training and psychoeducation / mindfulness for treatment of executive dysfunction in Parkinson's disease: A feasibility pilot trial.
    Giguère-Rancourt A; Plourde M; Racine E; Couture M; Langlois M; Dupré N; Simard M
    PLoS One; 2022; 17(2):e0263108. PubMed ID: 35180229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of COVID-19 Confinement on Cognition and Mental Health and Technology Use Among Socially Vulnerable Older People: Retrospective Cohort Study.
    Dura-Perez E; Goodman-Casanova JM; Vega-Nuñez A; Guerrero-Pertiñez G; Varela-Moreno E; Garolera M; Quintana M; Cuesta-Vargas AI; Barnestein-Fonseca P; Gómez Sánchez-Lafuente C; Mayoral-Cleries F; Guzman-Parra J
    J Med Internet Res; 2022 Feb; 24(2):e30598. PubMed ID: 35049505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized controlled trial of the efficacy of cognitive training delivered using two different methods in mild cognitive impairment in Parkinson's disease: preliminary report of benefits associated with the use of a computerized tool.
    Bernini S; Panzarasa S; Barbieri M; Sinforiani E; Quaglini S; Tassorelli C; Bottiroli S
    Aging Clin Exp Res; 2021 Jun; 33(6):1567-1575. PubMed ID: 32895890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial magnetic stimulation improves cognition over time in Parkinson's disease.
    Trung J; Hanganu A; Jobert S; Degroot C; Mejia-Constain B; Kibreab M; Bruneau MA; Lafontaine AL; Strafella A; Monchi O
    Parkinsonism Relat Disord; 2019 Sep; 66():3-8. PubMed ID: 31300260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addenbrooke's Cognitive Examination validation in Parkinson's disease.
    Reyes MA; Perez-Lloret S; Roldan Gerschcovich E; Martin ME; Leiguarda R; Merello M
    Eur J Neurol; 2009 Jan; 16(1):142-7. PubMed ID: 19049504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.
    Orgeta V; McDonald KR; Poliakoff E; Hindle JV; Clare L; Leroi I
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD011961. PubMed ID: 32101639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goal-orientated cognitive rehabilitation for dementias associated with Parkinson's disease-A pilot randomised controlled trial.
    Hindle JV; Watermeyer TJ; Roberts J; Brand A; Hoare Z; Martyr A; Clare L
    Int J Geriatr Psychiatry; 2018 May; 33(5):718-728. PubMed ID: 29314218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.
    Schrag A; Siddiqui UF; Anastasiou Z; Weintraub D; Schott JM
    Lancet Neurol; 2017 Jan; 16(1):66-75. PubMed ID: 27866858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised.
    Sobreira E; Pena-Pereira MA; Eckeli AL; Sobreira-Neto MA; Chagas MH; Foss MP; Cholerton B; Zabetian CP; Mata IF; Tumas V
    Arq Neuropsiquiatr; 2015 Nov; 73(11):929-33. PubMed ID: 26517216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting cognitive impairment in patients with Parkinson's disease with a brief cognitive screening tool: the Addenbrooke's Cognitive Examination (ACE).
    Chade A; Roca M; Torralva T; Gleichgerrcht E; Fabbro N; Arévalo GG; Gershanik O; Manes F
    Dement Neuropsychol; 2008; 2(3):197-200. PubMed ID: 29213570
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.